A quick guide to greenlight laser prostatectomy

Written in association with: Mr Marcus Cumberbatch
Published:
Edited by: Conor Dunworth

Greenlight laser prostatectomy (GLLP) is a treatment that can help patients who struggle to pass urine. In his latest online article, renowned consultant urological surgeon Mr Marcus Cumberbatch offers his expert insight into this treatment. He explains how the procedure works, when it is required and the recovery time among other interesting points.

 

What is green light laser prostate surgery?

Greenlight laser prostatectomy (GLLP) is an operation performed to improve the ability of men to pass urine. GLLP helps to widen the waterpipe and reduce the blockage caused by a large prostate. GLLP is a novel operation, that has largely replaced the traditional cautery (TURP) operation used to help men with this issue. GLLP uses a green laser to vaporise (remove) the excess prostate.

 

When is it required?

As men get older, the prostate often enlarges. This is a benign (non-cancerous) growth. Sometimes, this growth results in a partial blockage of urine exiting the bladder when we pee. As such, men may experience frequent trips to the toilet, getting up at night to pee, poor stream and emptying. In more severe cases, men may suffer infections or bladder stones. Occasionally, men end up with a catheter.

 

How long does it take, and is it safe/painful?

Men can expect a 1-hour procedure, and to be able to return home the same day (day case). A catheter is worn for 3-5 days. One of the chief benefits of the GLLP is that the laser does not cause bleeding and therefore the operation is often more convenient and tolerated.

 

What are the associated risks?

The risks/side-effects of a GLLP include:

  • Urine infection (5%)
  • Retrograde ejaculation (reduced semen volume during orgasm, 50%,
  • Scar formation in the waterpipe (2%)
  • No improvement in symptoms (1%)
  • Problems regaining control of passing urine (treated with retraining exercises, 1%)
  • Anaesthetic reactions (<1%).

 

What is recovery time like?

Men will be home the same day or sometimes the following day. Driving and light activities can resume within 1-2 days. Once the catheter is removed after 3-5 days, men are normally able to live as usual. Men are normally asked to refrain from heavy lifting for 6 weeks. A clinic follow-up is booked for 6-8 weeks after the operation to check symptoms have improved.

 

Mr Marcus Cumberbatch is a highly experienced consultant urological surgeon based in Sheffield and Nottinghamshire. If you would like to book a consultation with Mr Cumberbatch you can do so today via his Top Doctors profile

By Mr Marcus Cumberbatch
Urology

Mr Marcus Cumberbatch is a leading consultant urological surgeon based in Sheffield and Nottingham, who specialises in prostate cancer, prostate biopsy and bladder problems alongside bladder cancer, benign prostate disease and diagnostic treatment. He privately practises at The Thornbury Hospital, Spire Hospital Claremont and The Park Hospital, while his NHS base is Royal Hallamshire Hospital. He is also the Cancer Lead of the directorate.

Mr Cumberbatch has an impressive educational CV, with an MBBS from University College London and MRCS from the Royal College of Surgeons of England. As part of his medical school training, Mr Cumberbatch attended the Welcome Institute where he obtained a scholarship to complete an Intercalated BSc in the History of Medicine.

Further educational achievements include foundation training in the Nottingham Deanery, the Academic Clinical Fellowship and a PhD in Cancer Biology. He was also awarded an Academic Clinical Lectureship by the National Institute for Health Research (NIHR) and was granted the Ellison-Cliffe Foundation Award by the Royal Society of Medicine (RSM) where he learnt about robot-assisted surgery and novel cancer diagnostics in Melbourne, Australia.   

Mr Cumberbatch is highly respected among his peers, and he has presented at various international conferences in countries including Japan, Spain and Denmark. He holds several leadership positions including principal investigator on a number of NIHR portfolio clinical trials investigating the use of robotics in minimally-invasive surgery, patient outcome meetings and cancer screening.  

His clinical research has featured in a selection of peer-reviewed journals, and he has an international reputation for his cancer epidemiology knowledge. Mr Cumberbatch is a member of various professional organisations, including the European Association of Urology (EAU) and the Medical Defence Union (MDU). Furthermore, he's a fellow of the Royal College of Surgeons of Edinburgh.      
 
In 2021, Mr Cumberbatch published an international multicentre series showing that robotic surgery can be used even in high-risk situations where kidney function is poor or only one kidney is present. These patients previously may have been facing open surgery or lifelong dialysis, but with robotic techniques can now be offered a keyhole operation to remove the cancer with less complications, faster recovery, and preserved kidney function. 

View Profile

Overall assessment of their patients


  • Related procedures
  • Sexually transmitted infections (STIs)
    Vaginoplasty
    Penis Enlargement (Phalloplasty)
    Adult circumcision
    Laparoscopy
    Urologic Oncology
    Geriatric Urology
    Kidney transplantation
    Phimosis
    Short frenulum
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.